Chief Division of Nephrology UC Davis, Vice Chair Biochemistry and Molecular Medicine
Nephrology
Dr. George A. Kaysen, MD
|
|
Give Review
George A. Kaysen, MD works in the field of Nephrology. He researched medicine at Albert Einstein College of Medicine at Jacobi Medical Center. He received 1 awards: "Fellow (ASNF)". George Kaysen is a published doctor. He has 101 papers published. The most current publication "Mechanism of hypoalbuminemia in the 7/8-nephrectomized rat with chronic renal failure." George Kaysen is registered with Medicare and accepts Medicare payments.
Publications
- Validating Appetite Assessment Tools Among Patients Receiving Hemodialysis.
- Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
- Outcomes of Infection-Related Hospitalization in Medicare Beneficiaries Receiving In-Center Hemodialysis.
- Agreement of Single- and Multi-Frequency Bioimpedance Measurements in Hemodialysis Patients: An Ancillary Study of the Frequent Hemodialysis Network Daily Trial.
- Comparison of Self-report-Based and Physical Performance-Based Frailty Definitions Among Patients Receiving Maintenance Hemodialysis.
- Apolipoprotein L1 gene variants associate with prevalent Kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
- Effect of change in fluid distribution in segments in hemodialysis patients at different ultrafiltration rates on accuracy of whole body bioimpedance measurement.
- Calibration of the Brief Food Frequency Questionnaire Among Patients on Dialysis.
- Progressive inflammation and wasting in patients With ESRD.
- Comparison of Hospitalization Rates among For-Profit and Nonprofit Dialysis Facilities.
- Changes in serum inflammatory markers are associated With changes in apolipoprotein A1 but not B after the initiation of dialysis.
- Comparison of fluid volume estimates in Chronic hemodialysis patients by bioimpedance, direct isotopic, and dilution methods.
- Vitamin D Deficiency and Mortality in Patients Receiving Dialysis: The Comprehensive Dialysis Study.
- Comparison of Bioimpedance and Dual-Energy X-Ray Absorptiometry for Measurement of Fat Mass in Hemodialysis Patients.
- Prealbumin is Associated With Visceral Fat Mass in Patients Receiving Hemodialysis.
- Longitudinal measures of serum albumin and prealbumin concentrations in incident dialysis patients: the comprehensive dialysis study.
- Dietary protein restriction and preservation of Kidney function in chronic Kidney disease.
- Effect of frequent hemodialysis on residual Kidney function.
- Modeling time-varying effects With generalized and unsynchronized longitudinal data.
- Association of Physical Activity With Survival among Ambulatory Patients on Dialysis: The Comprehensive Dialysis Study.
- Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: The comprehensive dialysis study.
- Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels.
- The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial.
- Dialysis: Obesity and mortality on dialysis-does age matter?
- Risk of Cardiovascular Events after Infection-Related Hospitalizations in Older Patients on Dialysis.
- Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study.
- Imaging apolipoprotein AI in vivo.
- Association of Self-reported Physical Activity With Laboratory Markers of Nutrition and Inflammation: The Comprehensive Dialysis Study.
- New insights into lipid metabolism in chronic Kidney disease.
- Low level of self-reported physical activity in ambulatory patients new to dialysis.
- Infection-related hospitalizations in older patients With ESRD.
- Biochemistry and biomarkers of inflamed patients: why look, what to assess.
- Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients.
- Potential restoration of HDL function with apolipoprotein A-I mimetic peptide in end-stage renal Disease.
- The comprehensive dialysis study (CDS): a USRDS special study.
- Lipid and lipoprotein metabolism in chronic Kidney disease.
- Estimation of adipose pools in hemodialysis patients from anthropometric measures.
- Higher serum creatinine concentrations in black patients with chronic Kidney disease: beyond nutritional status and body composition.
- Trends and outcomes associated With serum albumin concentration among incident dialysis patients in the United States.
- Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials.
- Reverse epidemiology: a confusing, confounding, and inaccurate term.
- GFR, body mass index, and low high-density lipoprotein concentration in adults With and Without CKD.
- Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the rat.
- Disorders in high-density metabolism with insulin resistance and chronic Kidney disease.
- Challenging the validity of the EPO index.
- Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients.
- Diabetes, a cause of progressive sarcopenia in dialysis patients?
- Estimation of total-body and limb muscle mass in hemodialysis patients by using multifrequency bioimpedance spectroscopy.
- Graded effects of proteinuria on HDL structure in nephrotic rats.
- Effects of inflammation on plasma composition and endothelial structure and function.
- Assessment of body composition in long-term hemodialysis patients: rationale and methodology.
- Inflammation: cause of vascular Disease and malnutrition in dialysis patients.
- Association of body size With outcomes among patients beginning dialysis.
- The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis.
- The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients With minor renal dysfunction.
- Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction With HDL.
- Serum albumin concentration in dialysis patients: why does it remain resistant to therapy?
- Characteristics and effects of inflammation in end-stage renal Disease.
- Increased albumin and fibrinogen synthesis rate in patients with chronic renal Failure.
- On-line clearance: a useful tool for monitoring the effectiveness of the reuse procedure.
- Breath ethane in dialysis patients and control subjects.
- Why measure serum albumin levels?
- Factors that affect albumin concentration in dialysis patients and their relationship to vascular Disease.
- Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients.
- Inflammation in ESRD: causes and potential consequences.
- Serum markers of periodontal Disease status and inflammation in hemodialysis patients.
- Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rate.
- Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients.
- Hyperlipidemia in chronic Kidney disease.
- The effect of lipoproteins on the development and progression of renal Disease.
- New insights into lipid metabolism in chronic Kidney disease: what are the practical implications?
- The effect of etanercept on suppression of the systemic inflammatory response in Chronic hemodialysis patients.
- Prediction, progression, and outcomes of chronic Kidney disease in older adults.
- National Kidney Foundation consensus conference on cardiovascular and Kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events.
- Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial.
- Cerebrovascular Disease in maintenance hemodialysis patients: results of the HEMO Study.
- Association between inflammation and malnutrition as risk factors of cardiovascular Disease.
- Metabolic syndrome and renal Failure: similarities and differences.
- Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients.
- Metabolic consequences of body size and body composition in hemodialysis patients.
- Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
- Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion.
- Measuring partial body potassium in the arm versus total body potassium.
- Dialysis removes apolipoprotein C-I, improving very low-density lipoprotein clearance.
- The role of improved water quality on inflammatory markers in patients undergoing regular dialysis.
- Inflammation and inverse associations of body mass index and serum creatinine With mortality in hemodialysis patients.
- The pharmacokinetics of etanercept in patients with end-stage renal Disease on haemodialysis.
- Segment-specific resistivity improves body fluid volume estimates from bioimpedance spectroscopy in hemodialysis patients.
- The spectrum of infection-related morbidity in hospitalized haemodialysis patients.
- Inflammation and reduced albumin synthesis associated With stable decline in serum albumin in hemodialysis patients.
- Pharmacokinetics of thalidomide in patients With impaired renal function and while on and off dialysis.
- Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.
- Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels ...
- Impact of albumin synthesis rate and the Acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients.
- Daily dialysis in North America: evidence for a bright future.
- Association of serum albumin and atherosclerosis in Chronic hemodialysis patients.
- Mechanism of hypoalbuminemia in the 7/8-nephrectomized rat with chronic renal Failure.
- Role of inflammation and its treatment in ESRD patients.
- Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients.
- Lower C-reactive protein and better hemodialysis survival are associated With regular exercise activity: Longitudinal outcomes from the ACTIVE-ADIPOSE special study.
Schools
Albert Einstein College of Medicine of Yeshiva University
Bronx Muni Hospital
Einstein
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Chronic Glomerulonephritis
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Fellow (ASNF)
Education
-
Albert Einstein College of Medicine at Jacobi Medical Center -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
University of California, Davis Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083698617 |
| Last Name Of The Provider | KAYSEN |
| First Name Of The Provider | GEORGE |
| View All |
Similar Doctors
|
|
Dr. Burl R. Don, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose A. Morfin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Naveen K. Atray, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas A. Depner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James J. Gehrig Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Satpreet S. Sekhon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Johan Winoto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew I. Chin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Viput Mantadilok, MD |
|
|
Dr. David Pai, MD
This Doctor is OpenDoctor Recommended.
|